New Onset Diabetes After Organ Transplantation: Risk Factors, Treatment, and Consequences
Diagnostics · 25.01.2025 · 15 (3) · 284
DOI: 10.3390/diagnostics15030284 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 25.01.2025. Verfasst von Lucija Popović und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, University Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
New onset diabetes mellitus after organ transplantation (NODAT) is a frequent and serious complication of solid organ transplantation. It significantly impacts graft function, patient survival, and quality of life. NODAT is diagnosed based on the criteria for type 2 diabetes, with the oral glucose tolerance test (OGTT) serving as the gold standard for diagnosis. The development of NODAT is influenced by a range of risk factors, which are classified into modifiable and non-modifiable categories. Post-transplant, regular glycemic monitoring at specific intervals is essential for timely diagnosis and initiation of therapy. Early intervention can help prevent or delay the onset of diabetes-related complications. The treatment strategy for NODAT involves lifestyle modifications and pharmacological interventions. These include medications such as metformin, sulfonylureas, glinides, thiazolidinediones, DPP-4 inhibitors, GLP-1 agonists, SGLT-2 inhibitors, and insulin. Adjusting immunosuppressive therapy—either by reducing dosages or substituting drugs with lower diabetogenic potential—is a common preventative and therapeutic measure. However, this must be performed cautiously to avoid acute graft rejection, which poses a greater risk to the patient compared to NODAT itself. In addition to managing diabetes, addressing comorbidities such as hypertension and dyslipidemia is crucial, as they elevate the risk of cardiovascular events and mortality. Patients with NODAT are also prone to developing common diabetes-related complications, including diabetic nephropathy, neuropathy, retinopathy, and peripheral vascular disease. Therefore, regular follow-ups and appropriate treatment are vital to maintaining quality of life and improving long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, University Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia.
- School of Medicine, University of Zagreb, Šalata 3, 10000 Zagreb, Croatia.
- Department of Diabetes and Endocrinology, Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, Dugi dol 4a, 10000 Zagreb, Croatia.
ORCID-Profile: Tomislav Bulum
Zitieren
APA
Popović, L., & Bulum, T. (2025). New Onset Diabetes After Organ Transplantation: Risk Factors, Treatment, and Consequences. Diagnostics, 15(3), 284. https://doi.org/10.3390/diagnostics15030284
Vancouver
Popović L, Bulum T. New Onset Diabetes After Organ Transplantation: Risk Factors, Treatment, and Consequences. Diagnostics. 2025;15(3):284. doi:10.3390/diagnostics15030284
BibTeX
@article{Popovi2025,
author = {Popović, Lucija and Bulum, Tomislav},
title = {New Onset Diabetes After Organ Transplantation: Risk Factors, Treatment, and Consequences},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {3},
pages = {284},
doi = {10.3390/diagnostics15030284}
}
EUVIMED